Improvement in Quality of Life in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy and Cardiomyopathy Treated with Inotersen in the Phase 3 Study NEURO-TTR
Publication date: March–April 2020Source: Heart & Lung, Volume 49, Issue 2Author(s): Spencer Guthrie
Source: Heart and Lung: The Journal of Acute and Critical Care - Category: Respiratory Medicine Source Type: research
More News: Amyloidosis | Brain | Cardiology | Cardiomyopathy | Heart | Neurology | Respiratory Medicine | Study